Virus therapy trial targets tough cancers
NCT ID NCT07154108
Summary
This early-stage study is testing the safety of a new two-part treatment for people with advanced head & neck cancer or a type of esophageal cancer that has returned or spread. The treatment involves injecting a modified virus directly into a tumor to block its blood supply, while also giving an immunotherapy drug by IV to help the immune system fight the cancer. The main goal is to see how safe this combination is and what side effects it might cause.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.